146 related articles for article (PubMed ID: 29345206)
1. Successful treatment of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation with bortezomib.
Cao L; Koh LP; Linn YC
Leuk Lymphoma; 2018 Oct; 59(10):2500-2502. PubMed ID: 29345206
[No Abstract] [Full Text] [Related]
2. Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant.
Mehta B; Mahadeo K; Zaw R; Tang S; Kapoor N; Abdel-Azim H
Pediatr Blood Cancer; 2014 Dec; 61(12):2324-5. PubMed ID: 25131654
[No Abstract] [Full Text] [Related]
3. Clofarabine-based regimen as useful bridge therapy for allogeneic transplantation in myeloid blast crisis of Philadelphia-positive chronic myeloid leukemia resistant to imatinib and dasatinib.
Breccia M; Capria S; Iori AP; Foà R; Alimena G; Meloni G
Acta Haematol; 2010; 124(3):150-2. PubMed ID: 20938169
[No Abstract] [Full Text] [Related]
4. Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia.
Nishimoto M; Nakamae H; Koh KR; Kosaka S; Matsumoto K; Morita K; Koh H; Nakane T; Ohsawa M; Hino M
Acta Haematol; 2013; 130(2):111-4. PubMed ID: 23548721
[TBL] [Abstract][Full Text] [Related]
5. Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia.
Chen Z; Medeiros LJ; Kantajian HM; Zheng L; Gong Z; Patel KP; Xiong H; Wang W; Cortes JE; Hu S
Blood Cancer J; 2017 Feb; 7(2):e521. PubMed ID: 28157214
[No Abstract] [Full Text] [Related]
6. Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT.
Simms-Waldrip T; Ikeda A; Goldfinger D; Moore T; Yuan S
Bone Marrow Transplant; 2010 Jan; 45(1):201-2. PubMed ID: 19448677
[No Abstract] [Full Text] [Related]
7. Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.
Park JA; Lee HH; Kwon HS; Baik CR; Song SA; Lee JN
Transfus Med Rev; 2016 Jan; 30(1):6-14. PubMed ID: 26481836
[TBL] [Abstract][Full Text] [Related]
8. Durable molecular response to imatinib mesylate following nonmyeloablative allogeneic stem-cell transplantation for persisting myeloid blast crisis in chronic myeloid leukemia.
Staber PB; Brezinschek R; Linkesch W; Sill H; Neumeister P
Haematologica; 2003 Aug; 88(8):ECR29. PubMed ID: 12935988
[TBL] [Abstract][Full Text] [Related]
9. Taming of the shrew--overcoming extramedullary blast crisis in the era of the new tyrosine kinase inhibitors.
Raanani P
Acta Haematol; 2013; 130(2):108-10. PubMed ID: 23548690
[No Abstract] [Full Text] [Related]
10. Extramedullary relapse of chronic myeloid leukemia in blast crisis: more questions than answers.
Ross DM
Leuk Lymphoma; 2009 Apr; 50(4):517-8. PubMed ID: 19373644
[No Abstract] [Full Text] [Related]
11. Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation.
Prestes DP; Arbona E; Nevett-Fernandez A; Woolley AE; Ho VT; Koo S; Baden LR; Koreth J; Hammond SP; Issa NC; Marty FM
Clin Infect Dis; 2017 Aug; 65(3):510-513. PubMed ID: 28419210
[TBL] [Abstract][Full Text] [Related]
12. Successful HLA-identical unrelated allogeneic bone marrow transplantation with a very low dose of stem cells for a patient with chronic myeloid leukemia in blast crisis.
Arai H; Arai Y; Haraguchi K; Nakamura Y; Tsurumi S; Maki K; Aoyagi A; Nakamura Y; Saito K; Mitani K
Leuk Lymphoma; 2002 Oct; 43(10):2067-9. PubMed ID: 12481912
[No Abstract] [Full Text] [Related]
13. When to Consider Allogeneic Transplantation in CML.
Radich J
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S93-5. PubMed ID: 27521333
[TBL] [Abstract][Full Text] [Related]
14. Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Przepiorka D; Khouri I; Thall P; Mehra R; Lee MS; Ippoliti C; Giralt S; Gajewski J; van Besien K; Andersson B; Körbling M; Deisseroth AB; Champlin R
Bone Marrow Transplant; 1999 May; 23(10):977-81. PubMed ID: 10373061
[TBL] [Abstract][Full Text] [Related]
15. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease.
Raj A; Bertolone S; Cheerva A
J Pediatr Hematol Oncol; 2004 May; 26(5):312-4. PubMed ID: 15111785
[TBL] [Abstract][Full Text] [Related]
17. [A case of chronic myelogenous leukemia responding to imatinib mesilate (Glivec) after relapse of blastic crisis following allogeneic bone marrow transplantation].
Fujisawa S; Yano K; Kobayashi M
Gan To Kagaku Ryoho; 2003 Mar; 30(3):427-30. PubMed ID: 12669406
[TBL] [Abstract][Full Text] [Related]
18. [National guidelines for treatment of chronic myelogenous leukemia].
Wisløff F; Brinch L; Hammerstrøm J
Tidsskr Nor Laegeforen; 2003 Jan; 123(2):157-9. PubMed ID: 12607495
[No Abstract] [Full Text] [Related]
19. Intensive chemotherapy and autologous hematopoietic stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast crisis chronic myeloid leukaemia.
Heim D; Friess D; Christen S; Stüssi G; Meyer-Monard S; Tichelli A; Passweg JR; Gratwohl A
Leukemia; 2006 May; 20(5):898-900. PubMed ID: 16525490
[No Abstract] [Full Text] [Related]
20. Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.
Nakamura Y; Tokita K; Nagasawa F; Takahashi W; Nakamura Y; Sasaki K; Ichikawa M; Mitani K
Int J Hematol; 2016 Mar; 103(3):348-53. PubMed ID: 26662559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
